世界の個別化医療市場2021-2028:製品別(個別化医療看護、個別化栄養&健康、DTC診断、遠隔医療、補完医療)

◆英語タイトル:Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medical Care, Personalized Nutrition & Wellness, DTC Diagnostics, Telemedicine, Complementary Medicine), And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MY050
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年5月18日
◆ページ数:221
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の個別化医療市場規模が2028年までに7,968億ドルに達すると予測しています。2021年から2028年までに年平均6.2%成長する見通しです。本市場調査資料では、個別化医療の世界市場について調査し、エグゼクティブサマリー、調査手法、市場変動・動向・範囲、競争分析、製品別(個別化診断、個別化治療、個別化看護、個別化栄養&健康管理)分析、地域別分析、企業情報など、以下の構成でまとめております。
・エグゼクティブサマリー
・調査手法
・市場変動・動向・範囲
・競争分析
・世界の個別化医療市場規模:製品別(個別化診断、個別化治療、個別化看護、個別化栄養&健康管理)
・世界の個別化医療市場規模:地域別
・企業情報
【レポートの概要】

Table of Contents

Chapter 1 Executive Summary
1.1 Personalized Medicine Market Outlook, 2017 – 2028
1.2 Personalized Medicine Market: Segment Outlook, 2017 – 2028
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR’s Internal Database
2.1.3 Secondary sources:
2.1.4 Third Party Perspective:
2.1.5 Primary Research:
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region wise market: Base estimates
2.4.2 Global market: CAGR calculation
2.4.3 Region based segment share calculation
Chapter 3 Market Variables, Trends& Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ ancillary market outlook
3.2 Penetration & Growth Prospect Mapping for PM Diagnostics & PM Therapeutics, 2020
3.3 Penetration & Growth Prospect Mapping for PM Medical Care & PM Nutrition & Wellness, 2020
3.4 Cost Structure Analysis
3.5 User Perspective Analysis
3.5.1 Consumer behaviour analysis
3.5.2 Market influencer analysis
3.6 Technology Overview
3.6.1 OMICs technology
3.6.1.1 Cross-technology coordination
3.6.1.2 Data management: Analytics, sharing, security, and storage
3.6.2 Sequencing technology
3.6.3 Polymerase Chain Reaction(PCR)
3.6.4 In situ hybridization
3.6.5 Immunohistochemistry
3.6.6 Other technologies
3.7 Regulatory Framework
3.7.1 Reimbursement framework
3.8 Product Pipeline Analysis
3.9 Personalized Medicine Market- Market Dynamics
3.9.1 Market driver analysis
3.9.1.1 Advancements in next generation sequencing technology
3.9.1.2 Expanding portfolio of companion/associated diagnostics
3.9.1.3 Increasing number of retail clinics across the developed regions of North America and Europe
3.9.1.4 Increasing prevalence of cancer & usage of biomarkers for PM cancer therapy
3.9.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.9.2 Market restraint analysis
3.9.2.1 Lack of proper intellectual property regulations for personalized medical technologies
3.9.2.2 Non-structural development of biomarkers
3.9.3 Market challenge analysis
3.9.3.1 Burden of proof is greater for clinical validation for PM therapeutics
3.10 SWOT By PESTLE Analysis
3.10.1 Political landscape
3.10.2 Economic landscape
3.10.3 Social landscape
3.10.4 Technology landscape
3.11 Industry Analysis – Porter’s
3.11.1 Bargaining power of suppliers: Moderate
3.11.2 Bargaining power of buyers: Moderate
3.11.3 Threat of substitution: Low
3.11.4 Threat of new entrants: Moderate
3.11.5 Competitive rivalry: High
3.12 Market Entry Strategies
3.12.1 Diagnostics companies:
3.12.2 Pharmaceutical and biotechnology companies
3.12.3 Raw material supplier
3.12.4 Distributor
3.12.5 Collaborations between diagnostic and pharma entities
3.13 Personalized Medicine – Application Growth Prospects Analysis
3.13.1 Personalized medicine – Application opportunity v/s implementation
3.13.2 Personalized medicine – Application opportunities prioritized
3.14 COVID-19 Impact on Personalized Medicine Market
Chapter 4 Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.4 Key Company Market Share Analysis/Ranking, 2020
4.4.1 Company financial size
4.4.2 Product portfolio
4.4.3 Geographic footprint
4.4.4 Innovation
4.4.5 Pipeline
4.4.6 Strategic initiatives
4.5 Public Companies
4.5.1 Company market position analysis
4.5.1.1 Number of products
4.5.1.2 Market penetration
4.5.1.3 Strategic initiatives
4.5.1.4 Segment coverage
4.5.1.5 Geographical presence
4.5.1.6 Conclusion
4.5.2 Competitive dashboard analysis
4.5.3 Market differentiators
4.5.4 Synergy analysis: Major deals & strategic alliances
4.6 Private Companies
4.6.1 List of key emerging companies
4.6.2 Funding outlook
4.6.3 Regional network map
4.6.4 Company market position analysis
4.6.5 List of suppliers
Chapter 5 Personalized Medicine Market Categorization: Product Estimates & Trend Analysis
5.1 Market: Product Movement Analysis
5.2 Personalized Medicine Diagnostics
5.2.1 Market, 2017 – 2028 (USD Billion)
5.2.2 Genetic testing
5.2.2.1 Market, 2017 – 2028 (USD Billion)
5.2.3 Direct-to-consumer (DTC) diagnostics
5.2.3.1 Market, 2017 – 2028 (USD Billion)
5.2.4 Esoteric lab services
5.2.4.1 Market, 2017 – 2028 (USD Billion)
5.2.5 Esoteric lab tests
5.2.5.1 Market, 2017 – 2028 (USD Billion)
5.3 PM Therapeutics
5.3.1 Market, 2017 – 2028 (USD Billion)
5.3.2 Pharmaceuticals
5.3.2.1 Market, 2017 – 2028 (USD Billion)
5.3.3 Genomic medicine
5.3.3.1 Market, 2017 – 2028 (USD Billion)
5.3.4 Medical devices
5.3.4.1 Market, 2017 – 2028 (USD Billion)
5.4 Personalized Medical Care
5.4.1 Market, 2017 – 2028 (USD Billion)
5.4.2 Telemedicine
5.4.2.1 Global Telemedicine Market, 2017 – 2028 (USD Billion)
5.4.3 Health Information Technology
5.4.3.1 Market, 2017 – 2028 (USD Billion)
5.5 Personalized Nutrition & Wellness
5.5.1 Market, 2017 – 2028 (USD Billion)
5.5.2 Retail Nutrition
5.5.2.1 Market, 2017 – 2028 (USD Billion)
5.5.3 Complementary & Alternative Medicine
5.5.3.1 Market, 2017 – 2028 (USD Billion)
Chapter 6 Personalized Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product
6.1 Market Share by Region, 2018 & 2025
6.2 North America
6.2.1 Market, 2017 – 2028 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.2.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.2.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.2.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.2.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.2.3 Canada
6.2.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.2.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.2.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.2.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.2.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3 Europe
6.3.1 Market, 2017 – 2028 (USD Billion)
6.3.2 Germany
6.3.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.3 U.K.
6.3.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.4 Italy
6.3.4.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.4.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.4.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.4.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.4.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.5 France
6.3.5.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.5.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.5.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.5.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.5.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4 Asia Pacific
6.4.1 Market, 2017 – 2028 (USD Billion)
6.4.2 Japan
6.4.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.3 China
6.4.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.4 India
6.4.4.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.4.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.4.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.4.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.4.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.5 South Korea
6.4.5.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.5.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.5.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.5.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.5.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.5 Latin America
6.5.1 Market, 2017 – 2028 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.5.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.5.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.5.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.5.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.5.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.5.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.5.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.5.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.6 Middle East & Africa
6.6.1 Market, 2017 – 2028 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.6.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.6.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.6.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.6.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.6.3 Saudi Arabia
6.6.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.6.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.6.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.6.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.6.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 GE Healthcare
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Illumina, Inc.
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 ASURAGEN, INC.
7.3.3.1 Company overview
7.3.3.2 Product benchmarking
7.3.3.3 Strategic initiatives
7.3.4 Danaher
7.3.4.1 Company overview
7.3.4.2 Cepheid
7.3.4.2.1 Company overview
7.3.4.3 Financial performance
7.3.4.4 Product benchmarking
7.3.4.5 Strategic initiatives
7.3.5 Abbott Laboratories
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Exact Sciences Corporation
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Biogen International
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Exagen Inc.
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.8.3 Strategic initiatives
7.3.9 Genelex Corporation
7.3.9.1 Company overview
7.3.9.2 Product benchmarking
7.3.9.3 Strategic initiatives
7.3.10 Precision Biologics, Inc.
7.3.10.1 Company overview
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives
7.3.11 QIAGEN
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 IBM
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Genentech, Inc.
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 23andME, Inc.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Personalized Medicine Market Outlook, 2017 – 2028
1.2 Personalized Medicine Market: Segment Outlook, 2017 – 2028
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR’s Internal Database
2.1.3 Secondary sources:
2.1.4 Third Party Perspective:
2.1.5 Primary Research:
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region wise market: Base estimates
2.4.2 Global market: CAGR calculation
2.4.3 Region based segment share calculation
Chapter 3 Market Variables, Trends& Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ ancillary market outlook
3.2 Penetration & Growth Prospect Mapping for PM Diagnostics & PM Therapeutics, 2020
3.3 Penetration & Growth Prospect Mapping for PM Medical Care & PM Nutrition & Wellness, 2020
3.4 Cost Structure Analysis
3.5 User Perspective Analysis
3.5.1 Consumer behaviour analysis
3.5.2 Market influencer analysis
3.6 Technology Overview
3.6.1 OMICs technology
3.6.1.1 Cross-technology coordination
3.6.1.2 Data management: Analytics, sharing, security, and storage
3.6.2 Sequencing technology
3.6.3 Polymerase Chain Reaction(PCR)
3.6.4 In situ hybridization
3.6.5 Immunohistochemistry
3.6.6 Other technologies
3.7 Regulatory Framework
3.7.1 Reimbursement framework
3.8 Product Pipeline Analysis
3.9 Personalized Medicine Market- Market Dynamics
3.9.1 Market driver analysis
3.9.1.1 Advancements in next generation sequencing technology
3.9.1.2 Expanding portfolio of companion/associated diagnostics
3.9.1.3 Increasing number of retail clinics across the developed regions of North America and Europe
3.9.1.4 Increasing prevalence of cancer & usage of biomarkers for PM cancer therapy
3.9.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.9.2 Market restraint analysis
3.9.2.1 Lack of proper intellectual property regulations for personalized medical technologies
3.9.2.2 Non-structural development of biomarkers
3.9.3 Market challenge analysis
3.9.3.1 Burden of proof is greater for clinical validation for PM therapeutics
3.10 SWOT By PESTLE Analysis
3.10.1 Political landscape
3.10.2 Economic landscape
3.10.3 Social landscape
3.10.4 Technology landscape
3.11 Industry Analysis – Porter’s
3.11.1 Bargaining power of suppliers: Moderate
3.11.2 Bargaining power of buyers: Moderate
3.11.3 Threat of substitution: Low
3.11.4 Threat of new entrants: Moderate
3.11.5 Competitive rivalry: High
3.12 Market Entry Strategies
3.12.1 Diagnostics companies:
3.12.2 Pharmaceutical and biotechnology companies
3.12.3 Raw material supplier
3.12.4 Distributor
3.12.5 Collaborations between diagnostic and pharma entities
3.13 Personalized Medicine – Application Growth Prospects Analysis
3.13.1 Personalized medicine – Application opportunity v/s implementation
3.13.2 Personalized medicine – Application opportunities prioritized
3.14 COVID-19 Impact on Personalized Medicine Market
Chapter 4 Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.4 Key Company Market Share Analysis/Ranking, 2020
4.4.1 Company financial size
4.4.2 Product portfolio
4.4.3 Geographic footprint
4.4.4 Innovation
4.4.5 Pipeline
4.4.6 Strategic initiatives
4.5 Public Companies
4.5.1 Company market position analysis
4.5.1.1 Number of products
4.5.1.2 Market penetration
4.5.1.3 Strategic initiatives
4.5.1.4 Segment coverage
4.5.1.5 Geographical presence
4.5.1.6 Conclusion
4.5.2 Competitive dashboard analysis
4.5.3 Market differentiators
4.5.4 Synergy analysis: Major deals & strategic alliances
4.6 Private Companies
4.6.1 List of key emerging companies
4.6.2 Funding outlook
4.6.3 Regional network map
4.6.4 Company market position analysis
4.6.5 List of suppliers
Chapter 5 Personalized Medicine Market Categorization: Product Estimates & Trend Analysis
5.1 Market: Product Movement Analysis
5.2 Personalized Medicine Diagnostics
5.2.1 Market, 2017 – 2028 (USD Billion)
5.2.2 Genetic testing
5.2.2.1 Market, 2017 – 2028 (USD Billion)
5.2.3 Direct-to-consumer (DTC) diagnostics
5.2.3.1 Market, 2017 – 2028 (USD Billion)
5.2.4 Esoteric lab services
5.2.4.1 Market, 2017 – 2028 (USD Billion)
5.2.5 Esoteric lab tests
5.2.5.1 Market, 2017 – 2028 (USD Billion)
5.3 PM Therapeutics
5.3.1 Market, 2017 – 2028 (USD Billion)
5.3.2 Pharmaceuticals
5.3.2.1 Market, 2017 – 2028 (USD Billion)
5.3.3 Genomic medicine
5.3.3.1 Market, 2017 – 2028 (USD Billion)
5.3.4 Medical devices
5.3.4.1 Market, 2017 – 2028 (USD Billion)
5.4 Personalized Medical Care
5.4.1 Market, 2017 – 2028 (USD Billion)
5.4.2 Telemedicine
5.4.2.1 Global Telemedicine Market, 2017 – 2028 (USD Billion)
5.4.3 Health Information Technology
5.4.3.1 Market, 2017 – 2028 (USD Billion)
5.5 Personalized Nutrition & Wellness
5.5.1 Market, 2017 – 2028 (USD Billion)
5.5.2 Retail Nutrition
5.5.2.1 Market, 2017 – 2028 (USD Billion)
5.5.3 Complementary & Alternative Medicine
5.5.3.1 Market, 2017 – 2028 (USD Billion)
Chapter 6 Personalized Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product
6.1 Market Share by Region, 2018 & 2025
6.2 North America
6.2.1 Market, 2017 – 2028 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.2.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.2.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.2.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.2.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.2.3 Canada
6.2.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.2.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.2.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.2.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.2.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3 Europe
6.3.1 Market, 2017 – 2028 (USD Billion)
6.3.2 Germany
6.3.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.3 U.K.
6.3.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.4 Italy
6.3.4.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.4.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.4.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.4.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.4.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.3.5 France
6.3.5.1 Market, by product, 2017 – 2028 (USD Billion)
6.3.5.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.3.5.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.3.5.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.3.5.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4 Asia Pacific
6.4.1 Market, 2017 – 2028 (USD Billion)
6.4.2 Japan
6.4.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.3 China
6.4.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.4 India
6.4.4.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.4.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.4.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.4.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.4.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.4.5 South Korea
6.4.5.1 Market, by product, 2017 – 2028 (USD Billion)
6.4.5.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.4.5.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.4.5.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.4.5.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.5 Latin America
6.5.1 Market, 2017 – 2028 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.5.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.5.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.5.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.5.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.5.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.5.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.5.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.5.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.6 Middle East & Africa
6.6.1 Market, 2017 – 2028 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market, by product, 2017 – 2028 (USD Billion)
6.6.2.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.6.2.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.6.2.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.6.2.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
6.6.3 Saudi Arabia
6.6.3.1 Market, by product, 2017 – 2028 (USD Billion)
6.6.3.2 Market, by personalized medicine diagnostics, 2017 – 2028 (USD Billion)
6.6.3.3 Market, by personalized medicine therapeutics, 2017 – 2028 (USD Billion)
6.6.3.4 Market, by personalized medical care, 2017 – 2028 (USD Billion)
6.6.3.5 Market, by personalized nutrition & wellness, 2017 – 2028 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 GE Healthcare
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Illumina, Inc.
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 ASURAGEN, INC.
7.3.3.1 Company overview
7.3.3.2 Product benchmarking
7.3.3.3 Strategic initiatives
7.3.4 Danaher
7.3.4.1 Company overview
7.3.4.2 Cepheid
7.3.4.2.1 Company overview
7.3.4.3 Financial performance
7.3.4.4 Product benchmarking
7.3.4.5 Strategic initiatives
7.3.5 Abbott Laboratories
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Exact Sciences Corporation
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Biogen International
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Exagen Inc.
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.8.3 Strategic initiatives
7.3.9 Genelex Corporation
7.3.9.1 Company overview
7.3.9.2 Product benchmarking
7.3.9.3 Strategic initiatives
7.3.10 Precision Biologics, Inc.
7.3.10.1 Company overview
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives
7.3.11 QIAGEN
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 IBM
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Genentech, Inc.
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 23andME, Inc.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 FDA-approved and CE-marked tests with an epigenetic component
TABLE 3 Pipeline program of Cellworks
TABLE 4 List of distributors and channel partners
TABLE 5 List of emerging companies
TABLE 6 List of suppliers
TABLE 7 Healthcare expenditure levels, 2020
TABLE 8 North America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 9 North America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 10 North America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 11 North America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 12 North America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 13 U.S. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 14 U.S. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 15 U.S. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 16 U.S. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 17 U.S. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 18 Canada personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 19 Canada market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 20 Canada market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 21 Canada market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 22 Canada market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 23 Europe personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 24 Europe market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 25 Europe market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 26 Europe market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 27 Europe market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 28 Germany personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 29 Germany market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 30 Germany market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 31 Germany market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 32 Germany market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 33 U.K. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 34 U.K. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 35 U.K. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 36 U.K. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 37 U.K. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 38 Italy personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 39 Italy market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 40 Italy market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 41 Italy market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 42 Italy market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 43 France personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 44 France market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 45 France market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 46 France market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 47 France market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 48 Asia Pacific personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 49 Asia Pacific market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 50 Asia Pacific market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 51 Asia Pacific market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 52 Asia Pacific market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 53 Japan personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 54 Japan market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 55 Japan market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 56 Japan market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 57 Japan market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 58 China personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 59 China market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 60 China market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 61 China market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 62 China market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 63 India personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 64 India market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 65 India market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 66 India market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 67 India market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 68 South Korea personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 69 South Korea market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 70 South Korea market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 71 South Korea market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 72 South Korea market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 73 Latin America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 74 Latin America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 75 Latin America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 76 Latin America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 77 Latin America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 78 Brazil personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 79 Brazil market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 80 Brazil market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 81 Brazil market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 82 Brazil market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 83 Mexico personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 84 Mexico market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 85 Mexico market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 86 Mexico market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 87 Mexico market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 88 MEA personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 89 MEA market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 90 MEA market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 91 MEA market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 92 MEA market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 93 South Africa personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 94 South Africa market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 95 South Africa market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 96 South Africa market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 97 South Africa market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
TABLE 98 Saudi Arabia personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
TABLE 99 Saudi Arabia market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
TABLE 100 Saudi Arabia market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
TABLE 101 Saudi Arabia market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
TABLE 102 Saudi Arabia market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)


List of Figures

FIG. 1 Market segmentation & scope
FIG. 2 Market summary
FIG. 3 Market research process
FIG. 4 Information procurement
FIG. 5 Primary research pattern
FIG. 6 Market research approaches
FIG. 7 Value chain-based sizing & forecasting
FIG. 8 QFD modelling for market share assessment
FIG. 9 Parent market outlook
FIG. 10 Penetration & growth prospect mapping for PM diagnostics & PM therapeutics, 2020
FIG. 11 Penetration & growth prospect mapping for PM medical care & PM nutrition & wellness, 2020
FIG. 12 Consumer awareness of personalized medicine
FIG. 13 PCR-based platforms for mutation detection
FIG. 14 Companion diagnostics pipeline, as of March 2020
FIG. 15 Market trends & outlook
FIG. 16 Market driver relevance analysis (Current & future impact)
FIG. 17 DNA sequencing cost per genome
FIG. 18 Global cancer incidence, as of September 2020
FIG. 19 Use of cancer biomarkers in cancer management
FIG. 20 Expected rise in expenditure for cancer treatment (USD Billion)
FIG. 21 Growth in number of personalized medicines available in the U.S. from 2008 to 2020
FIG. 22 Market restraint relevance analysis (Current & future impact)
FIG. 23 Business models for market entry
FIG. 24 Marketing channels
FIG. 25 Personalized medicine - application opportunity v/s implementation
FIG. 26 Personalized medicine - Application opportunities prioritized
FIG. 27 Impact analysis by key companies
FIG. 28 Company categorization
FIG. 29 Heat map analysis of top key players, 2020
FIG. 30 Public companies market position analysis
FIG. 31 Competitive dashboard analysis for public players
FIG. 32 Regional network map for private players
FIG. 33 Personalized medicine market: Product outlook key takeaways
FIG. 34 Personalized medicine market: Product movement analysis
FIG. 35 Global personalized medicine diagnostics market, 2017 - 2028 (USD Billion)
FIG. 36 Global genetic testing market, 2017 - 2028 (USD Billion)
FIG. 37 Global DTC diagnostics market, 2017 - 2028 (USD Billion)
FIG. 38 Global esoteric lab services market, 2017 - 2028 (USD Billion)
FIG. 39 Global esoteric lab tests market, 2017 - 2028 (USD Billion)
FIG. 40 Global personalized medicine therapeutics market, 2017 - 2028 (USD Billion)
FIG. 41 Global pharmaceuticals market, 2017 - 2028 (USD Billion)
FIG. 42 Global genomic medicine market, 2017 - 2028 (USD Billion)
FIG. 43 Global medical devices market, 2017 - 2028 (USD Billion)
FIG. 44 Global personalized medical care market, 2017 - 2028 (USD Billion)
FIG. 45 Global telemedicine market, 2017 - 2028 (USD Billion)
FIG. 46 Global health information technology market, 2017 - 2028 (USD Billion)
FIG. 47 Global personalized nutrition & wellness market, 2017 - 2028 (USD Billion)
FIG. 48 Global retail nutrition market, 2017 - 2028 (USD Billion)
FIG. 49 Global complementary & alternative medicine market, 2017 - 2028 (USD Billion)
FIG. 50 Regional market place: Key takeaway
FIG. 51 Personalized medicine regional outlook, 2020 & 2028
FIG. 52 North America personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 53 U.S. personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 54 Canada personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 55 Europe personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 56 Germany personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 57 U.K. personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 58 Italy personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 59 France personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 60 Asia Pacific personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 61 Japan personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 62 China personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 63 India personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 64 South Korea personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 65 Latin America personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 66 Brazil personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 67 Mexico personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 68 Middle East & Africa personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 69 South Africa personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 70 Saudi Arabia personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 71 Strategy framework
FIG. 72 Participant categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の個別化医療市場2021-2028:製品別(個別化医療看護、個別化栄養&健康、DTC診断、遠隔医療、補完医療)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆